期刊文献+

血红蛋白水平对维持性血液透析患者心血管事件发生的影响 被引量:3

下载PDF
导出
摘要 目的:观察维持性血液透析患者血红蛋白水平对心血管事件发生的影响。方法:选取符合治疗时间≥3个月、规律性透析、治疗规范、依从性好、定期监测血指标患者198例。每月监测患者血常规,每3个月监测患者血脂、钙、磷等指标。随访1年,记录患者心血管事件和因心血管事件死亡情况。分析不同血红蛋白水平对心血管事件的影响。结果:低血红蛋白组(Hb<110g/L)心血管事件发病率最高,为62.0%(62/100),目标血红蛋白组(110g/L≤Hb≤120g/L)最低,为30.2%(16/53),两组比较P<0.05。高血红蛋白组(Hb>120g/L)发病率为55.6%(25/45),与目标血红蛋白组比较P<0.05。因心血管事件病死率低血红蛋白组最高,为19.0%(19/100),目标血红蛋白组最低,为3.8%(2/53),两组比较P<0.05。高血红蛋白组病死率为14.6%(8/45),与目标血红蛋白组比较P<0.05。结论:血红蛋白水平影响心血管事件的发生,低于或高于目标血红蛋白水平均有较高的心血管事件发病率。
出处 《中国中西医结合肾病杂志》 2013年第8期711-713,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
  • 相关文献

参考文献13

  • 1陈月梅,季大玺,徐斌,陶静,龚德华,刘志红,黎磊石.维持性血液透析患者高血压影响因素的分析[J].肾脏病与透析肾移植杂志,2008,17(2):128-134. 被引量:19
  • 2KDIGO Summary of Recommendation Statements. Kidney Int Suppl,2012 ,2 :283 - 287.
  • 3Pereira AA, Sarnak MJ. Anemia as a risk factor for cardiovascular disease. Kidney Int Supp1,2003, (87) : $32 - $39.
  • 4Gilbertson DT, Ebben JP, Foley RN, et al. Hemoglobin level vari- ability :associations with mortality. Clin J Am Soc Nephrol,2008, 3(1) :133 -138.
  • 5Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of oe- dema in chronic severe anaemia: Studies of body water and sodi- um, renal function, hcmodynamic variables, and plasma hor- mones. Br Heart J,1993,70(4) :357 - 362.
  • 6Avram MM, Blasurein D, Fein PA, et al. Hemoglobin predicts long- term survival in dialysis patients :a 15 -year single -cen- ter longitudinal study and correlation trend between prealbumin and hemoglobin. Kidney Int Suppl,2003, (87) :$6 -S11.
  • 7NKF - DOQI clinical practice guidelines for the treatment of ane- mia of chronic renal failure. National Kidney Foundation - Dialy- sis Outcomes Quality Initiative. Am J Kidney Dis, 1997,30(4 Suppl 3) :S192 - S240.
  • 8Ofsthun N, Labrecque J, Lacson E, et al. The effects of higher he- moglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int ,2003,63 (5) : 1908 - 1914.
  • 9Szczech LA, Bamhart HX, Inrig JK,et al. Secondary analysis of the CHOIR trial epoetin a dose and achieved hemoglobin out- comes. Kidney Int,2008,74(6) :791 -798.
  • 10. Parfrey PS. Double - blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol,2005,16:2180 - 2189.

二级参考文献16

  • 1中国人民解放军肾脏病专业协作组.2001例血液透析患者病因分析及高血压和贫血治疗状况[J].中国血液净化,2005,4(5):235-238. 被引量:77
  • 2戴兵,梅长林.透析高血压的发病机制及治疗进展[J].中国血液净化,2007,6(1):5-7. 被引量:34
  • 3季大玺.维持性血液透析患者高血压治疗的对策[J].肾脏病与透析肾移植杂志,2007,16(2):152-153. 被引量:18
  • 4叶朝阳.维持性血液透析患者高血压的诊断和治疗[J].肾脏病与透析肾移植杂志,2007,16(2):156-157. 被引量:11
  • 5Ⅳ. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease:Update 2000. Am J Kidney Dis,2001,37 (Suppl 1 ) : S182 - S238.
  • 6Mittal SK, Kowalski E, Trenkle J,et al. Prevalence of hypertension in a hemodialysis population. Clin Nephrol, 1999,51 (2) :77 - 82.
  • 7Rahman M, Fu P, Sehgal AR,et al. Interdialytic weight gain, compliance with dialysis regimen and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis, 2000,35 (2) :257 -265.
  • 8Charra B. From adequate to optimal dialysis Long 3 × 8 hr dialysis : a reasonable compromise. Nefrologia,2005,25 ( Suppl 2) : 19 - 24.
  • 9Grekas D, Kalevrosoglou I, Karamouzis M, et al. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Clin Nephrol,2001,55(2) :115 - 120.
  • 10Iseki K, Nakai S, Shinzato T, et al. Prevalence and determinants of hypertension in chronic hemodialysis patients in japan therapeutic apheresis and dialysis, Ther Apher Dial ,2007,11 ( 3 ) : 183 - 188.

共引文献18

同被引文献19

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部